Harbin Medisan Pharmaceutical Co., Ltd. (SZSE: 002900)
Health Care · Pharmaceuticals · CN
CN¥12.97
+2.85% today · +0.7% 1Y
Harbin Medisan Pharmaceutical Co., Ltd. (SZSE: 002900) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $611.69M and employs 2,086 people.
Over the last twelve months the share price has gained 0.7%, trading between 8.93 and 17.19.
Tweenvest scores Harbin Medisan Pharmaceutical Co., Ltd. across four factors: quality 55/100, value 60/100, growth 0/100. Its strongest factor is value.
002900 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $611.69M
- Revenue (TTM)
- $118.52M
- P/E
- —
- EPS
- -0.92
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- CN¥17.19
- 52-week low
- CN¥8.93
- Avg volume (3M)
- —
- Shares outstanding
- 316.35M
- Employees
- 2,086
- Next earnings
- —
About Harbin Medisan Pharmaceutical Co., Ltd.
Established in 1996 and based in Harbin, China, Harbin Medisan Pharmaceutical Co., Ltd. specializes in the full lifecycle of chemical pharmaceutical products within China, from research and development to manufacturing and sales. The company's comprehensive product line includes both active pharmaceutical ingredients (APIs) and various finished drug forms. Its offerings address a wide array of medical conditions, encompassing treatments for neurological, cardiovascular, and musculoskeletal systems, systemic infections, nutritional support, fluid balance, and other general healthcare needs.
- ISIN
- CNE1000032V9
- Founded
- 1996
- Listed since
- Sep 25, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TTY Biopharm Company LimitedTPEX: 4105 | $615.87M | NT$78.90 | +0.77% |
| Jianmin Pharmaceutical Group Co.,Ltd.SHSE: 600976 | $614.25M | CN¥26.86 | +0.22% |
| Shanghai New World Co., LtdSHSE: 600628 | $613.33M | CN¥6.36 | +1.27% |
| Newland Pharmaceutical Co., Ltd.SZSE: 301277 | $611.98M | CN¥10.47 | +2.25% |
| Shandong Wohua Pharmaceutical Co., Ltd.SZSE: 002107 | $610.10M | CN¥7.09 | -1.12% |
| ChengDu ShengNuo Biotec Co.,Ltd.SHSE: 688117 | $609.67M | CN¥18.56 | -1.38% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.SHSE: 600613 | $609.32M | CN¥8.19 | -0.73% |
| Jinling Pharmaceutical Company LimitedSZSE: 000919 | $602.66M | CN¥6.50 | +1.25% |
Figures last refreshed Oct 4, 2026.